Carterra

Exhibitor

Carterra® is a leading provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates. Since the Company’s first product launch in 2018, its Surface Plasmon Resonance (SPR) platforms have been adopted by all top 20 pharmaceutical companies, major CROs, and leading biotechs across the world.

Carterra’s high throughput LSA, LSA-XT, Ultra, and Vega platforms transform label-free characterization workflows, enabling screening and characterization for both large and small molecules in a single step.  The instruments combine patented microfluidics technology with real-time High-Throughput SPR (HT-SPR) and industry-leading analysis and visualization software – delivering up to 100 times the throughput in 10% of the time, while using only 1% of the sample compared to existing label-free platforms.

Carterra’s innovations have been featured in multiple Science, Nature, and Cell publications, including research documenting the development of bamlanivimab—the first therapeutic for COVID-19 and the fastest biologic ever to enter clinical trials, enabled through the efforts of Eli Lilly and AbCellera. More than a dozen of Carterra’s customers have identified clinical candidates rapidly utilizing HT-SPR technology.

Carterra, Inc. is based in Salt Lake City, Utah, and has Customer Experience Centers in San Francisco, Salt Lake City, Boston, Manchester (England), and Munich (Germany). Carterra products are available in Asia-Pacific and Oceania through our exclusive distributor, Revvity.

For additional information, please visit www.carterra-bio.com.

website